Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,449 | 210 | 99.6% |
| Education | $24.60 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $1,435 | 11 | $0 (2022) |
| Boston Scientific Corporation | $586.07 | 10 | $0 (2020) |
| Amarin Pharma Inc. | $529.81 | 27 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $393.39 | 27 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $358.98 | 18 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $327.91 | 19 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $247.85 | 15 | $0 (2022) |
| Astellas Pharma US Inc | $242.66 | 13 | $0 (2021) |
| Edwards Lifesciences Corporation | $221.02 | 5 | $0 (2022) |
| PFIZER INC. | $192.73 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $408.97 | 21 | Novartis Pharmaceuticals Corporation ($94.64) |
| 2021 | $581.06 | 32 | Amarin Pharma Inc. ($161.84) |
| 2020 | $544.64 | 21 | Amarin Pharma Inc. ($211.63) |
| 2019 | $823.29 | 41 | Abbott Laboratories ($175.71) |
| 2018 | $1,475 | 34 | Abbott Laboratories ($769.72) |
| 2017 | $1,641 | 64 | Abbott Laboratories ($302.52) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/01/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Cardiology | ||||||
| 09/06/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardiology | ||||||
| 08/30/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/12/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/11/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/11/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $29.62 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: DIABETES | ||||||
| 05/02/2022 | Abbott Laboratories | CONFIRM RX (Device) | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: Cardiac Rhythm Management | ||||||
| 04/26/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/22/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/31/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/30/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/28/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/17/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: DIABETES | ||||||
| 03/03/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: Cardiology | ||||||
| 02/17/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/02/2022 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Transcatheter Heart Valves | ||||||
| 01/26/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/20/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: DIABETES | ||||||
| 11/16/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: DIABETES | ||||||
| 11/10/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Cardiovascular | ||||||
| 11/09/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Cardiovascular | ||||||
| 10/20/2021 | ARBOR PHARMACEUTICALS, INC. | Edarbi (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 13 | 2,443 | 3,818 | $1.1M | $286,730 |
| 2021 | 15 | 2,603 | 4,130 | $1.2M | $319,899 |
| 2020 | 17 | 2,885 | 4,618 | $1.3M | $330,791 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 493 | 1,058 | $232,760 | $98,637 | 42.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 397 | 400 | $204,000 | $59,156 | 29.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 379 | 387 | $309,600 | $57,872 | 18.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 132 | 528 | $79,200 | $25,322 | 32.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 206 | 207 | $169,740 | $11,508 | 6.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 205 | 205 | $38,950 | $10,038 | 25.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 491 | 893 | $41,971 | $8,849 | 21.1% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 44 | 44 | $21,560 | $6,453 | 29.9% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2022 | 16 | 16 | $12,240 | $3,567 | 29.1% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2022 | 47 | 47 | $17,390 | $2,549 | 14.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2022 | 11 | 11 | $8,800 | $2,080 | 23.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2022 | 11 | 11 | $2,090 | $475.97 | 22.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2022 | 11 | 11 | $2,090 | $222.32 | 10.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 545 | 1,129 | $248,380 | $107,986 | 43.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 430 | 443 | $354,400 | $69,579 | 19.6% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 409 | 416 | $212,160 | $66,260 | 31.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 145 | 577 | $86,550 | $26,936 | 31.1% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 239 | 239 | $45,410 | $11,398 | 25.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 544 | 1,033 | $48,551 | $10,888 | 22.4% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 16 | 16 | $40,000 | $5,971 | 14.9% |
| 93922 | Ultrasound study of arteries of both arms and legs, limited | Office | 2021 | 86 | 87 | $71,340 | $5,026 | 7.0% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report | Office | 2021 | 70 | 71 | $26,270 | $3,979 | 15.1% |
| 93351 | Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Office | 2021 | 20 | 20 | $16,000 | $3,835 | 24.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $10,090 | $3,254 | 32.2% |
| 93975 | Ultrasound scan of abdominal, pelvic, and/or scrotal arterial inflow and venous outflow | Office | 2021 | 15 | 15 | $11,475 | $3,124 | 27.2% |
About Dr. Gary Weingarden, MD
Dr. Gary Weingarden, MD is a Cardiovascular Disease healthcare provider based in Richardson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1477501724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Weingarden, MD has received a total of $5,473 in payments from pharmaceutical and medical device companies, with $408.97 received in 2022. These payments were reported across 213 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,449).
As a Medicare-enrolled provider, Weingarden has provided services to 7,931 Medicare beneficiaries, totaling 12,566 services with total Medicare billing of $937,420. Data is available for 3 years (2020–2022), covering 45 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Richardson, TX
- Active Since 05/05/2006
- Last Updated 05/20/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1477501724
Products in Payments
- Vascepa (Drug) $529.81
- ELIQUIS (Drug) $520.64
- Confirm Rx (Device) $486.12
- ENTRESTO (Drug) $357.36
- MRI Ready Leads (Device) $302.52
- XARELTO (Drug) $247.85
- PRADAXA (Drug) $204.92
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $203.49
- Quadra Allure MP RF CRT Pacemkr (Device) $175.51
- BRILINTA (Drug) $166.50
- LEXISCAN (Drug) $158.54
- Quadra Assura CRT Defibrillator (Device) $156.53
- JARDIANCE (Drug) $154.06
- Agilis NxT EP Introducer (Device) $140.08
- WATCHMAN (Device) $133.99
- VIGILANT (Device) $127.16
- Intracardiac Echocardiography (ICE) (Device) $117.48
- EMBLEM (Device) $111.87
- Corlanor (Drug) $101.89
- THE LATITUDE PATIENT MANAGEMENT SYSTEM (Device) $94.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Richardson
Dr. Nhan Nguyen, Md, MD
Cardiovascular Disease — Payments: $37,689
Richard Ammar, Md, MD
Cardiovascular Disease — Payments: $16,572
Mohamad Kabach, M.d, M.D
Cardiovascular Disease — Payments: $15,117
Dr. Joshua Burak, Md, MD
Cardiovascular Disease — Payments: $14,099
Dr. Biren Parikh, Md, MD
Cardiovascular Disease — Payments: $7,966
Neil Phung, M.d, M.D
Cardiovascular Disease — Payments: $4,522